THALLIUM PERFUSION AND CARDIAC ENZYME ABNORMALITIES IN PATIENTS WITH FAMILIAL HYPERTROPHIC CARDIOMYOPATHY

被引：48
|
作者：
NAGATA, S
PARK, Y
MINAMIKAWA, T
YUTANI, C
KAMIYA, T
NISHIMURA, T
KOZUKA, T
SAKAKIBARA, H
NIMURA, Y
机构：
[1] NATL CARDIOVASC CTR, DEPT PATHOL, SUITA, OSAKA 565, JAPAN
[2] NATL CARDIOVASC CTR, DEPT PEDIAT, SUITA, OSAKA 565, JAPAN
[3] NATL CARDIOVASC CTR, DEPT RADIOL, SUITA, OSAKA 565, JAPAN
来源：
AMERICAN HEART JOURNAL | 1985年 / 109卷 / 06期
关键词：
D O I：
10.1016/0002-8703(85)90358-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1317 / 1322
页数：6
相关论文
共 50 条
  • [1] MAGNETIC-RESONANCE IMAGING IN FAMILIAL HYPERTROPHIC CARDIOMYOPATHY ASSOCIATED WITH ABNORMAL THALLIUM PERFUSION AND CARDIAC ENZYMES
    NISHIMURA, T
    NAGATA, S
    SAKAKIBARA, H
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1988, 52 (05): : 395 - 400
  • [2] IMPACT OF SURGICAL RELIEF OF OUTFLOW OBSTRUCTION ON THALLIUM PERFUSION ABNORMALITIES IN HYPERTROPHIC CARDIOMYOPATHY
    CANNON, RO
    DILSIZIAN, V
    OGARA, PT
    UDELSON, JE
    TUCKER, E
    PANZA, JA
    FANANAPAZIR, L
    MCINTOSH, CL
    WALLACE, RB
    BONOW, RO
    CIRCULATION, 1992, 85 (03) : 1039 - 1045
  • [3] Clinical and prognostic significance of dipyridamole stress thallium-201 perfusion abnormalities in patients with hypertrophic cardiomyopathy
    Yamada, M
    Elliott, PM
    Kaski, JC
    Prasad, K
    Gane, JN
    Doi, Y
    McKenna, WJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (02) : 6271 - 6271
  • [4] Dipyridamole stress thallium-201 perfusion abnormalities in patients with hypertrophic cardiomyopathy - Relationship to clinical presentation and outcome
    Yamada, M
    Elliott, PM
    Kaski, JC
    Prasad, K
    Gane, JN
    Lowe, CM
    Doi, Y
    McKenna, WJ
    EUROPEAN HEART JOURNAL, 1998, 19 (03) : 500 - 507
  • [5] Thallium 201 myocardial perfusion in patients with hypertrophic cardiomyopathy and DDD pacing
    LeHelloco, A
    Gras, D
    Devillers, A
    Pavin, D
    Daubert, JC
    Bourguet, P
    Almange, C
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (02) : 7963 - 7963
  • [6] DETECTION OF HYPERTROPHIC CARDIOMYOPATHY BY THALLIUM 201 MYOCARDIAL PERFUSION IMAGING
    BULKLEY, BH
    ROULEAU, J
    STRAUSS, HW
    PITT, B
    CIRCULATION, 1975, 52 (04) : 52 - 52
  • [7] Septal thickness and thallium 201 myocardial perfusion in patients with hypertrophic cardiomyopathy and DDD pacing
    Le Helloco, A
    Pavin, D
    Alberini, JL
    Bourguet, P
    Almange, C
    Daubert, JC
    XIII WORLD CONGRESS OF CARDIOLOGY: FREE PAPERS, 1998, : 679 - 682
  • [8] PERFUSION ABNORMALITIES IN HYPERTROPHIC CARDIOMYOPATHY: MECHANISMS AND PROGNOSTIC IMPORTANCE
    Raphael, Claire E.
    Cooper, Robert
    Mitchell, Frances
    Liew, Alphonsus
    Newsome, Simon
    O'Hanlon, Rory
    Parker, Kim H.
    Vassiliou, Vassilis
    Pennell, Dudley J.
    Keegan, Jennifer
    Frenneaux, Michael
    Stables, Rod H.
    Di Mario, Carlo
    Prasad, Sanjay K.
    HEART, 2018, 104 : A112 - A113
  • [9] MYOCARDIAL PERFUSION ABNORMALITIES IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY AND NORMAL CORONARY-ARTERIES
    OGARA, PT
    BONOW, RO
    DAMSKE, BA
    MARON, BJ
    SPIRITO, P
    BACHARACH, SL
    GREEN, MB
    LARSON, SM
    EPSTEIN, SE
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 7 (02) : A95 - A95
  • [10] Effects of diltiazem on myocardial perfusion abnormalities during exercise in patients with hypertrophic cardiomyopathy
    Sugihara H.
    Taniguchi Y.
    Ito K.
    Terada K.
    Matsumoto K.
    Kinoshita N.
    Azuma A.
    Ushijima Y.
    Maeda T.
    Nakagawa M.
    Annals of Nuclear Medicine, 1998, 12 (6) : 349 - 354
12345